SHSE •
Healthcare •
Biotechnology •
Quote as of 07/29/2026 15:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSHSE
Market Capitalization1,672.99 mln
Float85.72 mln
EPS
0.33
Marginal
P / E
21.58
Premium valuation
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-3.93
Highly reliable
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
0.13
Very low leverage
Business Description
Founded in 1999 and headquartered in Wuhan, China, Cabio Biotech specializes in producing and selling key nutritional ingredients, including arachidonic acid, docosahexaenoic acid, and beta-carotene. The company supplies these ingredients to makers of infant formula and health food products both in China and internationally. Cabio also offers a broader range of products serving human and animal nutrition, personal care, and synthetic biology markets.
